Skip to content
Screener
ALM

Alamar Biosciences

ALMR

Alamar Biosciences is a biotechnology company in the healthcare sector trading on XNAS, led by CEO Yuling Luo, with a market cap of $2.0B.

Market cap
$1.96B+20.8%
Revenue$26.0M+98.9%
Net income-$21.3M-178%
Free cash flow-$20.9M-53.8%
EPS (diluted)-$1.74-156%
Quarterly · Q1 2026 · change vs. Q1 2025

Earnings

Q1 2026 report

May 8, 2026
Revenue$26.0MBeat by $26.3KEPS-$1.74Miss by $0.03

Next report

Aug 10, 2026 (In 3 days)
Revenue estimate$25.9M
EPS estimate-$0.31

Financials

Q1 2026

Income statement

See full
Revenue$26.0M+98.9%
Gross profit$14.5M+126%
Operating income-$12.3M-44.4%
Net income-$21.3M-178%
EPS (diluted)-$1.74-156%

Balance sheet

See full
Cash & equivalents$64.6M—
Total debt$30.6M—
Total equity-$178.1M—
Total assets$186.5M—

Cash flow

See full
Operating cash flow-$20.3M-55.7%
CapEx$600.0K+8.3%
Free cash flow-$20.9M-53.8%

Valuation & ratios

Valuation

See full
Market cap$1.96B+20.8%
Enterprise value$1.93B—

Returns & leverage

See full
Current ratio5.9×—

Segments

By geography

See full
EMEA$4.0M+179%
Asia Pacific$2.4M+435%
Americas$1.3M+6,335%

By product

See full
Consumables$14.0M+178%
Instruments$7.4M+78.0%
Service$4.7M+27.8%

Profile

CountryUnited States of America
Listed2026
CEOYuling Luo
SectorHealthcare
IndustryBiotechnology
Websitealamarbio.com
FilingsSEC EDGAR

FAQ

What is Alamar Biosciences's market cap?
Alamar Biosciences (ALMR) has a market capitalization of $2.0B and trades on XNAS.
Where is Alamar Biosciences headquartered?
Alamar Biosciences is headquartered in United States of America. It has been publicly traded since 2026.